Design, synthesis, and cytotoxicity of indolizinoquinoxaline-5,12-dione derivatives, novel DNA topoisomerase IB inhibitors

Australian Journal of Chemistry

Volumn 63, Issue 7, 2010, Pages 1116-1121

  Shen, De Qing ^a   Wu, Ning ^a   Li, Yan Ping ^a   Wu, Zu Ping ^a   Zhang, Hong Bin ^b   Huang, Zhi Shu ^a   Gu, Lian Quan ^a   An, Lin Kun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangzhou Liuhuaqiao Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA CELLS; ANTICANCER DRUG; BREAST CARCINOMA CELLS; DNA TOPOISOMERASE; HETEROCYCLIZATIONS; LUNG CARCINOMA; MICROMOLAR RANGE; PHARMACOPHORES; PYRIDINE DERIVATIVES; TUMOUR CELLS;

BIOLOGICAL ORGANS; CELL CULTURE; DNA; SYNTHESIS (CHEMICAL);

GENES;

EID: 77954854265     PISSN: 00049425     EISSN: None     Source Type: Journal    
DOI: 10.1071/CH09580     Document Type: Article

References (22)

1. L. Stewart,M. R. Redinbo, X. Qiu,W. G. Hol, J. J. Champoux, Science 1998, 279, 1534. doi:10.1126/SCIENCE.279.5356.1534 (Pubitemid 28217077)
2. Y. H. Hsiang, R. Hertzberg, S. Hecht, L. F. Liu, J. Biol. Chem. 1985, 260, 14873.
3. J. J. Champoux, Prog. Nucleic Acid Res. Mol. Biol. 1998, 60, 111. doi:10.1016/S0079-6603(08)60891-0
4. M. Gupta, A. Fujimori, Y. Pommier, Biochim. Biophys. Acta 1995, 1262, 1.
5. J. C. Wang, Annu. Rev. Biochem. 1996, 65, 635. doi:10.1146/ ANNUREV.BI.65.070196.003223
6. Y. Pommier, Nat. Rev. Cancer 2006, 6, 789. doi:10.1038/NRC1977 (Pubitemid 44450467)
7. D. A. Koster, V. Croquette, C. Dekker, S. Shuman, N. H. Dekker, Nature 2005, 434, 671. doi:10.1038/NATURE03395 (Pubitemid 40488562)
8. A. L. Bodley,T.A. Shapiro, Proc. Natl.Acad. Sci. USA 1995, 92, 3726. doi:10.1073/PNAS.92.9.3726
9. Y. Cheng, L. K. An, N. Wu, X. D. Wang, X. Z. Bu, Z. S. Huang, L. Q. Gu, Bioorg. Med. Chem. 2008, 16, 4617. doi:10.1016/ J.BMC.2008.02.036
10. A. Defant, G. Guella, I. Mancini, Arch. Pharm. Chem. Life Sci. 2007, 340, 147. doi:10.1002/ARDP.200600160 (Pubitemid 46964351)
11. For analogous studies of the antiproliferative activity of indolizinophthalazine- 5,12-dione derivatives, see D.-Q. Shen, Z.-P. Wu, X.-W. Wu, Z.-Y. An, X.-Z. Bu, L. Q. Gu, Z.-S. Huang, L.-K. An, Eur. J. Med. Chem. 2010, 45, in press. doi:10.1016/J.EJMECH.2010.05.048
12. J. S. Kim, H. J. Lee, M. E. Suh, H. Y. P. Choo, S. K. Lee, H. J. Park, C. Kim, S. W. Park, C. O. Lee, Bioorg. Med. Chem. 2004, 12, 3683. doi:10.1016/J.BMC.2004.04.014 (Pubitemid 38746871)
13. I. A. Shaikh, F. Johnson, A. P. Grollman, J. Med. Chem. 1986, 29, 1329. doi:10.1021/JM00158A002
14. F. Alvarez, A. Gherardi, P. Nebois, M. E. Sarciron, A. F. Petavy, N.Walchshofer, Bioorg. Med. Chem. Lett. 2002, 12, 977. doi:10.1016/ S0960-894X(02)00064-71
15. D. Q. Shen, Y. Cheng, L. K. An, X. Z. Bu, Z. S. Huang, L. Q. Gu, Chin. Chem. Lett. 2008, 19, 533. doi:10.1016/J.CCLET.2008.03.034
16. A. Defant, G. Guella, I. Mancini, Eur. J. Org. Chem. 2006, 4201. doi:10.1002/EJOC.200600317
17. C. Lion, R. Baudry, M. Hedayatullah, L. Da, Conceicao, S. Genard, J. Maignan, J. Heterocycl. Chem. 2002, 39, 125. doi:10.1002/ JHET.5570390118
18. J. Carmichael,W. G. DeGraff,A. F. Gazdar, J.D. Minna, J. B. Mitchell, Cancer Res. 1987, 47, 936.
19. T. Mosmann, J. Immunol. Methods 1983, 65, 55. doi:10.1016/0022- 1759(83)90303-90304
20. L. F. Liu, K. G. Miller, Proc. Natl. Acad. Sci. USA 1981, 78, 3487. doi:10.1073/PNAS.78.6.3487 (Pubitemid 11059315)
21. Y. Yu, S. K. Singh, A. Liu, T. K. Li, L. F. Liu, E. J. LaVoie, Bioorg. Med. Chem. 2003, 11, 1475. doi:10.1016/S0968-0896(02)00604-1 (Pubitemid 36293541)
22. L. F. Liu, C. C. Liu, B. M. Alberts, Nature 1979, 281, 456. doi:10.1038/281456A0 (Pubitemid 10244266)